Mandate

Vinge has advised the owners of Swedish Oat Fiber in conjunction with the sale of the company to Naturex

November 14, 2017 Banking and Finance

Swedish Oat Fiber has a leading international market position as a producer of oat beta glucan, dietary fiber, oat oils and oat proteins for use in the food, health, cosmetics and animal food industries. The company’s head office and manufacturing facility is situated in Bua outside Gothenburg.

Naturex distributes, manufactures and markets natural special ingredients for the food, health and cosmetics industries. Naturex is listed on Euronext Paris and has its head office in Avignon, France, and employs 1 700 people over the entire world. In 2016, the group’s turnover was EUR 404.4 million. The acquisition accords with Naturex’s strategy to accelerate the development of its special production portfolio and will provide significant synergies with their business development model. Swedish Oat Fiber will also contribute to strengthening Naturex’s market position within the natural food segment.

Vinge’s team consisted of partner Björn Mullaart together with, among others, associates Fredrik Christiansson, Niklas Törnell and Freja Ljungdell Kristensen.

Livingstone acted as the financial advisor to Swedish Oat Fiber in the sales process.

Related

Vinge advises Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of Bizware

Vinge has advised the Nordic private equity firm Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of the data analytics and AI firm Bizware AB and its subsidiaries Bizware Lead AB and Bizware Nova AB.
September 11, 2025

Vinge has acted as local counsel supporting lead counsel Latham & Watkins in advising Cadence in connection with its acquisition of Hexagon’s Design & Engineering Business for approx. EUR 2.7 billion

Cadence (Nasdaq: CDNS) announced it has entered into a definitive agreement to acquire the Design & Engineering business of Hexagon AB, which includes its MSC Software business—a pioneer in engineering simulation and analysis solutions.
September 09, 2025

Vinge has advised Oncopeptides in connection with its rights issue

Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025